Myriad Genetics Inc
MYGNNasdaqCIK 899923HealthcareFiscal year ends Dec 31
Reports and events: 281 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2008:36 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-26-000094 |
| 2026-10-0916:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000899923-26-000084 |
| 2026-09-1608:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-26-000079 |
| 2026-07-3108:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000899923-26-000072 |
| 2026-07-3016:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-26-000070 |
| 2026-06-2308:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000899923-26-000062 |
| 2026-06-0416:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000899923-26-000059 |
| 2026-05-0606:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000899923-26-000038 |
| 2026-05-0516:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-26-000036 |
| 2026-04-1417:01 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0000899923-26-000031 |
| 2026-02-2416:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000899923-26-000018 |
| 2026-02-2316:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-26-000012 |
| 2026-01-1208:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-26-000003 |
| 2025-11-0406:18 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000899923-25-000112 |
| 2025-11-0420:42 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-25-000109 |
| 2025-11-0316:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-25-000103 |
| 2025-10-0716:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000899923-25-000096 |
| 2025-10-0316:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000899923-25-000091 |
| 2025-08-1808:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000899923-25-000089 |
| 2025-08-0606:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000899923-25-000086 |
| 2025-08-0516:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-25-000084 |
| 2025-07-3109:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000899923-25-000072 |
| 2025-06-0516:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000899923-25-000066 |
| 2025-05-0720:48 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000899923-25-000048 |
| 2025-05-0616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-25-000045 |
| 2025-04-0916:06 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0000899923-25-000028 |
| 2025-02-2816:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000899923-25-000019 |
| 2025-02-2416:26 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-25-000010 |
| 2025-01-1508:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-25-000002 |
| 2024-12-1016:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000899923-24-000065 |
| 2024-11-2616:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-24-000060 |
| 2024-11-0808:18 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000899923-24-000057 |
| 2024-11-0716:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000054 |
| 2024-10-0906:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000048 |
| 2024-09-0420:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-24-000045 |
| 2024-08-0708:22 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000899923-24-000041 |
| 2024-08-0616:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000036 |
| 2024-06-0616:06 ET | 8-K | 5.07 Shareholder vote results | 0000899923-24-000028 |
| 2024-06-0316:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-24-000027 |
| 2024-05-0808:14 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000899923-24-000026 |
| 2024-05-0716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000025 |
| 2024-04-1716:31 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0000899923-24-000022 |
| 2024-02-2808:31 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000899923-24-000018 |
| 2024-02-2716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000014 |
| 2024-01-1609:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000005 |
| 2023-12-2108:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-23-000117 |
| 2023-11-1316:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000899923-23-000110 |
| 2023-11-0921:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000899923-23-000102 |
| 2023-11-0708:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000899923-23-000087 |
| 2023-11-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-23-000083 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:12 ET. Listed shows no prices and gives no investment advice.